Deployment of Transchromosomal Bovine for Personalized Antimicrobial Therapy-Reference-Cited by-同舟云学术

Deployment of Transchromosomal Bovine for Personalized Antimicrobial Therapy

Published:2017-12-20 Issue:7 Volume:66 Page:1116-1119
ISSN:1058-4838
Container-title:Clinical Infectious Diseases
language:en
Short-container-title:

Author:

Silver Jared N¹²,Ashbaugh Cameron D¹²,Miles Jacob J³,Wu Hua³,Marecki Gregory T¹²,Hwang Joyce K¹²,Jiao Jin-An³,Abrams Mark¹²,Sullivan Eddie J³,Wesemann Duane R¹²

Affiliation:

1. Department of Medicine, Division of Infectious Diseases, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts

2. Division of Rheumatology, Immunology and Allergy, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts

3. SAb Biotherapeutics Inc, Sioux Falls, South Dakota

Funder

Brigham and Women’s Hospital

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Microbiology (medical)

Link

http://academic.oup.com/cid/article-pdf/66/7/1116/24398247/cix977.pdf

Reference12 articles.

1. Critical dependence on antibody for defence against mycoplasmas;Webster;Clin Exp Immunol,1988

2. Mycoplasmas and ureaplasmas in patients with hypogammaglobulinaemia and their role in arthritis: microbiological observations over twenty years;Furr;Ann Rheum Dis,1994

3. Mycoplasmal arthritis in patients with primary immunoglobulin deficiency: clinical features and outcome in 18 patients;Franz;Br J Rheumatol,1997

4. Antigen-specific human polyclonal antibodies from hyperimmunized cattle;Kuroiwa;Nat Biotechnol,2009

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Transchromosomic bovines‐derived broadly neutralizing antibodies as potent biotherapeutics to counter important emerging viral pathogens with a special focus on SARS‐CoV‐2, MERS‐CoV, Ebola, Zika, HIV‐1, and influenza A virus;Journal of Medical Virology;2022-06-11

2. Increased Antibody Avidity and Cross-Neutralization of Severe Acute Respiratory Syndrome Coronavirus 2 Variants by Hyperimmunized Transchromosomic Bovine–Derived Human Immunoglobulins for Treatment of Coronavirus Disease 2019;The Journal of Infectious Diseases;2022-02-01

3. Human immunoglobulin from transchromosomic bovines hyperimmunized with SARS-CoV-2 spike antigen efficiently neutralizes viral variants;Human Vaccines & Immunotherapeutics;2021-07-06

4. The race between drug introduction and appearance of microbial resistance. Current balance and alternative approaches;Current Opinion in Pharmacology;2019-10

5. Generation of H7N9-specific human polyclonal antibodies from a transchromosomic goat (caprine) system;Scientific Reports;2019-01-23